The Aestheticians Journal (AJ) welcomes scholarly, evidence-based articles covering clinical, aesthetic, procedural, therapeutic and scientific topics relevant to its readership.
Authors should select the article type that best reflects the actual nature and central focus of the manuscript.
Articles in which an individual patient case is the central focus, including case reports supported by relevant literature.
This category includes:
Articles in which a procedure, device, therapeutic intervention or treatment technique is the principal focus, including, where applicable, injectable treatments, lasers, energy-based devices, peels, microneedling, hair procedures and other medical or aesthetic procedures.
Short articles centered primarily on clinically relevant images or visual findings.
The appropriate article type should be selected according to the central purpose of the manuscript, rather than simply according to the presence of a particular treatment or procedure.
Submit the manuscript as an editable Microsoft Word (.doc/.docx) file.
Unless otherwise specified:
The journal generally expects approximately 8–13 relevant references, although the number may vary according to the nature and scope of the article.
For each author, provide:
Example:
Dr. Ananya Sharma, MBBS, MD (Dermatology), Consultant Dermatologist, Department of Dermatology, ABC Hospital, Mumbai, India
The presentation of qualifications, professional designations and affiliations should be consistent throughout the manuscript.
Identify the corresponding author and provide:
Authors are encouraged to provide an ORCID iD, where available.
The title should be concise, informative and representative of the manuscript.
It should:
The abstract should generally be 150–250 words.
Original study articles use a structured abstract.
All other article types use an unstructured abstract.
Background | Objective | Methods | Results | Conclusion
The Methods should briefly describe the study design, population, intervention/exposure, principal outcome measures and statistical approach where applicable.
The Results should present the principal findings, including relevant numerical data where appropriate.
Use an unstructured abstract that briefly presents the purpose or background of the article, the principal clinical/scientific information discussed and the main conclusion or clinical relevance.
A research-style Methods/Results structure should not be introduced when these elements are not applicable.
Provide 3–6 relevant keywords below the abstract.
Case-based articles should generally follow: Title → Author Information → Abstract → Keywords → Introduction → Case Report → Figures/Clinical Images → Treatment → Discussion → Conclusion → Declarations → References
Briefly establish the clinical/scientific background and explain the relevance of the case.
Present the patient information in a logical clinical sequence, including, where applicable:
The case report should retain the patient-specific information as the central narrative.
Discuss the broader treatment approach and relevant evidence where applicable. Patient-specific treatment details should remain within the Case Report.
Interpret the case in relation to relevant published literature. The discussion may address treatment rationale, clinical relevance, diagnostic considerations, etiology, recurrence, prevention and other relevant issues.
Provide the principal clinical learning point in a concise form.
Relevant case-report reporting guidance, including CARE, should be considered to ensure completeness without requiring every reporting item to become a separate heading.
Approximately 1900–2900 words, with reasonable flexibility according to the case.
Narrative and review articles should be organized according to the logic and purpose of the subject, rather than being forced into a fixed research structure.
A typical sequence may be:
Title → Author Information → Abstract → Keywords → Introduction/Background → Topic-Specific Sections → Clinical/Scientific Perspective, where applicable → Conclusion → Declarations → References
Headings should be adapted to the subject. References for should be specifically 10-20 Methods, Results and other research-specific sections should not be introduced unless original study data are being reported. Narrative articles should retain the contributor's substantive content and intended expert perspective while being organized into a clear, coherent and scholarly sequence.
Original studies should generally follow the IMRAD framework:
Title → Authors & Affiliations → Structured Abstract → Keywords → Introduction → Materials and Methods → Results → Discussion → Conclusion → Declarations → References
The Introduction should establish:
Describe, as applicable:
The methodology should provide sufficient information for the reader to understand how the study was conducted.
Present the findings in a logical sequence, including relevant participant characteristics, primary and secondary outcomes, statistical findings and adverse events where applicable. Tables, graphs, photographs and flow diagrams may be used where they improve presentation. Information should not be unnecessarily duplicated across the text, tables and figures.
Where applicable, discuss:
State the principal findings and their appropriate clinical or scientific relevance without introducing new information or overstating the evidence.
Approximately 1850–2500 words.
Procedural and treatment-based articles should generally follow:
Title → Authors & Affiliations → Unstructured Abstract → Keywords → Introduction → Mechanism of Action → Diagnostic & Pre-Procedural Evaluation → Treatment Protocol → Results, where original data are presented → Discussion → Advantages → Limitations → Complications & Risk Management → Conclusion → Declarations → References
Not every heading will be applicable to every procedure.
Explain the clinical rationale and relevance of the procedure or treatment.
Describe the relevant mechanism where appropriate.
Include relevant patient assessment and pre-procedural considerations.
Where applicable, describe:
Include a Results section when original clinical or procedural data are being presented.
Discuss the procedure or treatment in relation to available evidence.
Address these aspects where relevant to the procedure rather than adding them mechanically when they are not applicable.
Approximately 1850–3000 words.
Clinical Image articles should be concise and primarily focused on the diagnostic or educational value of the image.
The submission should include:
Tables and figures should be included when they meaningfully contribute to the article.
Authors should:
Clinical images should not contain unnecessary patient-identifying information.
For case reports and other articles containing identifiable patient information or clinical images, appropriate consent for publication should be obtained. Authors should remove unnecessary identifying information.
Research involving human participants should include appropriate ethics committee or institutional review information, where applicable.
Example:
Ethics Approval: The study was approved by the Institutional Ethics Committee of [Institution] (Approval No. XXXXX).
Where ethics approval is not applicable, this should be stated where appropriate.
Authors should provide the following declarations as applicable to the article.
Authors should disclose relevant financial and non-financial relationships or activities that could influence, or could reasonably be perceived to influence, the work.
Where there is none:
Conflict of Interest: The author(s) declare no conflict of interest.
All financial or material support for the work should be disclosed. Where there is none:
Funding: The authors received no specific funding for this work.
The journal recognizes that AI-assisted tools may be used at different levels during manuscript preparation.
Routine use of AI-enabled tools for basic spelling, grammar or language correction does not, by itself, require a substantive AI declaration, provided that the authors remain responsible for the final manuscript and the tool has not been used to generate substantive scientific content.
Authors should disclose substantive use of generative AI or AI-assisted tools where they have been used to:
Where substantive AI use has occurred, authors should identify the tool and describe its purpose.
[Name of tool] was used for [specific purpose]. The authors reviewed and approved the final manuscript and remain responsible for its accuracy, originality and integrity. AI tools must not be listed as authors. Authors remain responsible for verifying AI-assisted content, references, data, images and scientific claims. Where AI is used in research analysis, data generation or figure creation, its use should also be described in the appropriate methodological section.
Authors should consider the reporting guideline appropriate to the actual study or article design.
Examples include:
Reporting guidelines are intended to improve completeness of reporting and should not result in unnecessary headings
References should:
Authors and contributors may provide complete manuscripts, partial drafts, clinical information, treatment details, procedural information, tables, figures, study data and references.
Editorial processing may include language editing, organization, restructuring, sentence refinement and formatting.
Substantive clinical or scientific information provided by the contributor should be preserved, and editorial changes should not alter its intended meaning.
Submission of a manuscript implies that:
The journal may screen manuscripts for plagiarism, substantial textual overlap and other forms of inappropriate content reuse.
Submitted manuscripts undergo editorial screening followed, where applicable, by independent peer review.
The final editorial decision rests with the Editor-in-Chief or designated editorial authority.
Authors should not attempt to influence the peer-review process or contact reviewers regarding the evaluation of their manuscript.
Further information is available in the journal's Peer Review Policy.
Authors should submit:
The journal follows principles of responsible scholarly publishing and maintains separate policies addressing authorship, plagiarism, duplicate publication, fabrication and falsification, image manipulation, peer-review ethics, corrections, retractions, complaints and appeals, and editorial independence.
Authors should review the journal's Publication Ethics Policy before submission
The journal's editorial and publishing practices are informed by internationally recognized standards and reporting guidance.
International Committee of Medical Journal Editors (ICMJE)
ICMJE Recommendations
CARE Guidelines — Case Reports
CARE Guidelines
CONSORT — Randomized Trials
CONSORT Statement
STROBE — Observational Studies
STROBE Statement
PRISMA — Systematic Reviews
PRISMA Statement
Committee on Publication Ethics (COPE)
COPE Core Practices
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.